Status:

NOT_YET_RECRUITING

Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction

Lead Sponsor:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions:

Oral Squamous Cell Carcinoma (OSCC)

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this study is to retrospectively compare different types of free flaps to determine the most suitable free flap for functional reconstruction in oral squamous cell carcinoma patients follo...

Detailed Description

Oral squamous cell carcinoma (OSCC) severely impacts patients's quality of life (QoL). The combined treatment approach of surgery, radiation and chemotherapy can lead to oral function impairments, inc...

Eligibility Criteria

Inclusion

  • Patients with oral squamous cell carcinoma who have completed comprehensive imaging examinations before surgery.
  • Preoperative pathological biopsy confirmed as oral squamous cell carcinoma.
  • Patients with oral squamous cell carcinoma who have completed comprehensive laboratory tests before surgery.
  • Patients with oral squamous cell carcinoma who underwent tumor resection and flap reconstruction at our hospital.
  • Postoperative pathological diagnosis confirmed as oral squamous cell carcinoma.
  • Patients with oral squamous cell carcinoma who attend follow-up visits at 1, 3, 6, and 12 months post-surgery, completing all clinical examinations and questionnaires.

Exclusion

  • Patients with oral squamous cell carcinoma who lack imaging data or have artifacts affecting imaging results.
  • Patients with oral squamous cell carcinoma who have incomplete laboratory test results from our hospital.
  • Patients with oral squamous cell carcinoma with postoperative pathology that remains unclear or cannot be confirmed as oral squamous cell carcinoma.
  • Patients with oral squamous cell carcinoma who are unable to attend follow-up visits at 1, 3, 6, and 12 months.
  • Patients who do not complete the questionnaires as required during follow-up visits.

Key Trial Info

Start Date :

September 30 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 30 2025

Estimated Enrollment :

217 Patients enrolled

Trial Details

Trial ID

NCT06599801

Start Date

September 30 2024

End Date

September 30 2025

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sun Yat-sen Memorial Hospital, Sun Yat-sen Univerity

Guangzhou, Guangdong, China, 510120